To Evaluate the Safety, and Pharmacokinetics of Parscaclisib in Participants With Normal Hepatic Function and Hepatic Impairment.
Clinical trial NCT04831944 · COMPLETED
Trial details
- NCT number
- NCT04831944
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-29
- Primary completion
- 2022-03-10
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.